AGP Executive Report
Last update: an hour agoMedtech Financing: Healthcare Holding Schweiz AG, a major Swiss medtech distributor with Liechtensteinische Landesbank among its lenders, has closed CHF 80 million in syndicated financing to fund further acquisitions and growth. Cardiovascular Drug Watch: NewAmsterdam Pharma and Menarini received a positive CHMP opinion for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an EU marketing authorization decision expected in 2H26. Disability Benefits Rules: UK DWP guidance warns PIP claimants that holidays abroad longer than four weeks can trigger penalties or payment suspension unless they notify the DWP promptly and share travel details. Citizenship Test: The UK’s Life in the UK Test is required for many foreign applicants seeking British citizenship or settlement, with booking, cost, and exam structure set out by the government. Health & Wellness Context: A new piece on global literacy highlights how low adult reading rates—linked to conflict, poverty, and underfunded schooling—can undermine public health and long-term wellbeing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
